| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Adverse reaction caused by pepsin (disorder) |
Causative agent (attribute) |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Adverse reaction to diphenoxylate |
Causative agent (attribute) |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Adverse reaction to pectin |
Causative agent (attribute) |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Adverse reaction to emetic |
Causative agent (attribute) |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Adverse reaction to lipotropic drugs |
Causative agent (attribute) |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Adverse reaction to digestants NOS |
Causative agent (attribute) |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Adverse reaction to antidiarrheal drugs NOS |
Causative agent (attribute) |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Adverse reaction to other drugs primarily affecting the gastrointestinal system |
Causative agent (attribute) |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Adverse reaction to drugs primarily affecting the gastrointestinal system NOS |
Causative agent (attribute) |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Infliximab |
Is a |
True |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Adverse reaction to emetics NOS |
Causative agent (attribute) |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| agent antidiarrhéique |
Is a |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| [X]Agents primarily affecting the gastrointestinal system causing adverse effects in therapeutic use |
Causative agent (attribute) |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| [X]Other antacids and anti-gastric-secretion drugs causing adverse effects in therapeutic use |
Causative agent (attribute) |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| [X]Other agents primarily affecting the gastrointestinal system causing adverse effects in therapeutic use |
Causative agent (attribute) |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| [X]Unspecified agents primarily affecting the gastrointestinal system causing adverse effects in therapeutic use |
Causative agent (attribute) |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 3mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 3 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Medicinal product acting as gastric acidifier (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Peripherally acting antiobesity drug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely prochlorperazine mesilate 5 milligram/1 sachet conventional release effervescent oral granules (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely prochlorperazine maleate 3 milligram/1 each conventional release buccal tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prochlorperazine maleate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prochlorperazine maleate 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prochlorperazine mesylate 5mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| mésylate de prochlorpérazine 12,5 mg/mL, ampoule de 1 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely prochlorperazine maleate 5 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prochlorperazine maleate 25 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Analgesics with anti-emetics (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Bitters and tonics (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Gentian acid mixture |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing neurokinin 1 receptor antagonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aromatic agent (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing prochlorperazine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing prochlorperazine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prochlorperazine-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dimenhydrinate 50 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely dimenhydrinate 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| L-Glutamine 5g powder for oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dimenhydrinate 50mg/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing strychnine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Inflammatory bowel disease drug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Poisoning caused by antacid AND/OR antigastric secretion drug |
Causative agent (attribute) |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| médicament gastro-intestinal |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing glutamic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Medicinal product acting as antiflatulent agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| médicament anti-émétique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing clidinium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Methixene-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prochlorperazine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dimenhydrinate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing meclozine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Medicinal product acting as antispasmodic agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Antacid drug poisoning NOS |
Causative agent (attribute) |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| [X]Poisoning by other antacids and anti-gastric-secretion drugs |
Causative agent (attribute) |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Antispasmodics and other drugs altering gut motility |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Compound antispasmodics |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide [gastro-intestinal] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Drugs acting on the gall bladder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Medicinal product acting as adsorbent agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prochlorperazine [antipsych] [see dhe..] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prochlorperazine [nausea] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing glutamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| L-Glutamine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tonics |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Strychnine [no preparations] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing monoctanoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Meclozine 12.5mg pastille |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Monoctanoin 100%vv liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Meclozine hydrochloride 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Meclozine hydrochloride 12.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prochlorperazine maleate 15mg (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely prochlorperazine maleate 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Meclozine hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Meclozine hydrochloride 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prochlorperazine 10 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prochlorperazine edisylate 5mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prochlorperazine 15 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely prochlorperazine 2.5 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlordiazepoxide hydrochlori + clidinium bromide 5mg/2.5mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Oral form prochlorperazine m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing chlordiazepoxide hydrochloride and clidinium bromide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phosphorated carbohydrate solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prochlorperazine edisylate 5mg/mL injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prochlorperazine edisylate 5mg/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prochlorperazine edisylate 5mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Benzalkonium chloride 1 mg/g and dimeticone 220 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cetrimide 3 mg/g and dimeticone 1000 100 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dimeticone and zinc oxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ginger product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Oil of dill product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing anise oil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cetrimide- and dimeticone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dimeticone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dimeticone- and white paraffin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing benzalkonium and dimeticone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Gentiana lutea preparation (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing synthetic cannabinoid receptor agonist |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Methylnaltrexone (substance) |
Is a |
True |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Alvimopan (substance) |
Is a |
True |
Gastrointestinal agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]